Search for content, post, videos

Nanoform and AstraZeneca initiate technology evaluation

Nanoform has announced the initiation of a technology evaluation of Nanoform’s CESS Technology across a range of AstraZeneca’s pharmaceutical products. The initiation of this study is to assess the added value that Nanoform’s technology could deliver across the pharmaceutical value chain.
Already a subscriber Login

You have read all your free articles, to continue reading subscribe to read the rest of this content.